Last reviewed · How we verify
A Nasal Treatment for COVID-19 (COVD-TX)
The goal of this study is to test an investigational new inhaled medication called Optate.
Details
| Lead sponsor | Indiana University |
|---|---|
| Phase | PHASE2 |
| Status | RECRUITING |
| Enrolment | 40 |
| Start date | Tue Jun 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon Mar 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- COVID-19
- Healthy
Interventions
- Optate
- Placebo
Countries
United States